A detailed history of Baldrige Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Baldrige Asset Management LLC holds 1,283 shares of BMY stock, worth $73,554. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,283
Previous 1,258 1.99%
Holding current value
$73,554
Previous $91,000 2.2%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$65.71 - $74.53 $1,642 - $1,863
25 Added 1.99%
1,283 $89,000
Q3 2021

Oct 22, 2021

SELL
$59.17 - $69.31 $1,952 - $2,287
-33 Reduced 2.56%
1,258 $74,000
Q2 2021

Aug 03, 2021

BUY
$61.91 - $67.42 $79,925 - $87,039
1,291 New
1,291 $86,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Baldrige Asset Management LLC Portfolio

Follow Baldrige Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldrige Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldrige Asset Management LLC with notifications on news.